| Metric | Q3 2017 | Q2 2017 | Q3 2016 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $11M | — | $9M | — | 20.3% |
| Op. Income | $3M | — | $2M | — | 56.5% |
| Gross Margin | 68.9% | — | 52.4% | — | 16.4pp |
| Net Margin | 13.8% | — | 11.9% | — | 1.9pp |
| EPS (Diluted) | $0.01 | — | $0.01 | — | 39.3% |
| Free Cash Flow | $1M | — | -$5M | — | 130.9% |
| Item | Amount |
|---|---|
| REVENUE | $11M |
| Cost of Revenue | $3M |
| GROSS PROFIT | $8M |
| R&D Expenses | $0 |
| Selling & Marketing | $153.1K |
| General & Administrative | $4M |
| SG&A Expenses | $4M |
| Other Expenses | $1M |
| Operating Expenses | $5M |
| Cost & Expenses | $8M |
| OPERATING INCOME | $3M |
| Interest Income | $6M |
| Interest Expense | $3M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $3M |
| Income Tax Expense | $1M |
| Net Income from Continuing Ops | $2M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $2M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $2M |
| D&A | $197.8K |
| EBIT | $3M |
| EBITDA | $3M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $11M |
| Cost of Revenue | $3M |
| GROSS PROFIT | $8M |
| R&D Expenses | $0 |
| Selling & Marketing | $153.1K |
| General & Administrative | $4M |
| SG&A Expenses | $4M |
| Other Expenses | $1M |
| Operating Expenses | $5M |
| Cost & Expenses | $8M |
| OPERATING INCOME | $3M |
| Interest Income | $6M |
| Interest Expense | $3M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $3M |
| Income Tax Expense | $1M |
| Net Income from Continuing Ops | $2M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $2M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $2M |
| D&A | $197.8K |
| EBIT | $3M |
| EBITDA | $3M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $2M |
| Depreciation & Amortization | $197.8K |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | -$2M |
| Change in Working Capital | $3M |
| OPERATING CASH FLOW | $2M |
| Capital Expenditure | -$458.5K |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $273.2K |
| NET CASH FROM INVESTING | -$185.3K |
| Net Debt Issuance | -$552.9K |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | $8M |
| NET CASH FROM FINANCING | $7M |
| FREE CASH FLOW | $1M |
| Net Change in Cash | $9M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $22M |
| Short-Term Investments | $0 |
| Net Receivables | $0 |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $22M |
| PP&E (Net) | $3M |
| Goodwill | $0 |
| Intangible Assets | $2M |
| Long-Term Investments | $23M |
| Tax Assets | $0 |
| Other Non-Current Assets | $147M |
| TOTAL NON-CURRENT ASSETS | $175M |
| TOTAL ASSETS | $198M |
| Account Payables | $1M |
| Short-Term Debt | $0 |
| Deferred Revenue | $0 |
| Other Current Liabilities | -$11M |
| TOTAL CURRENT LIABILITIES | $11M |
| Long-Term Debt | $33M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $135M |
| TOTAL NON-CURRENT LIABILITIES | $169M |
| TOTAL LIABILITIES | $172M |
| Common Stock | $1M |
| Additional Paid-In Capital | $7M |
| Retained Earnings | $17M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $200.4K |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $25M |
| Minority Interest | $1M |
| TOTAL EQUITY | $27M |
| TOTAL LIABILITIES & EQUITY | $198M |
| Total Debt | $33M |
| Net Debt | $11M |
